HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.

Abstract
The mammalian target of rapamycin (mTOR) signaling pathway is aberrantly activated in polycystic kidney disease (PKD). Emerging evidence suggests that phospholipase D (PLD) and its product phosphatidic acid (PA) regulate mTOR activity. In this study, we assessed in vitro the regulatory function of PLD and PA on the mTOR signaling pathway in PKD. We found that the basal level of PLD activity was elevated in PKD cells. Targeting PLD by small molecule inhibitors reduced cell proliferation and blocked mTOR signaling, whereas exogenous PA stimulated mTOR signaling and abolished the inhibitory effect of PLD on PKD cell proliferation. We also show that blocking PLD activity enhanced the sensitivity of PKD cells to rapamycin and that combining PLD inhibitors and rapamycin synergistically inhibited PKD cell proliferation. Furthermore, we demonstrate that targeting mTOR did not induce autophagy, whereas targeting PLD induced autophagosome formation. Taken together, our findings suggest that deregulated mTOR pathway activation is mediated partly by increased PLD signaling in PKD cells. Targeting PLD isoforms with pharmacological inhibitors may represent a new therapeutic strategy in PKD.
AuthorsYang Liu, Andres Käch, Urs Ziegler, Albert C M Ong, Darren P Wallace, Alexandre Arcaro, Andreas L Serra
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e73173 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24009738 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Phosphatidic Acids
  • Protein Kinase Inhibitors
  • TOR Serine-Threonine Kinases
  • Phospholipase D
Topics
  • Animals
  • Cell Line
  • Cell Proliferation (drug effects)
  • Disease Models, Animal
  • Drug Synergism
  • Enzyme Activation (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Epithelial Cells (drug effects, metabolism)
  • Humans
  • Kidney Tubules (drug effects, metabolism)
  • Male
  • Models, Biological
  • Phagosomes (drug effects, metabolism)
  • Phosphatidic Acids (pharmacology)
  • Phospholipase D (antagonists & inhibitors, metabolism)
  • Polycystic Kidney Diseases (metabolism)
  • Protein Kinase Inhibitors (pharmacology)
  • Rats
  • Signal Transduction (drug effects)
  • TOR Serine-Threonine Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: